Search research articles
Contact Us
Filters
Showing results (241-250 of 263) with videos related to
Page
of 27
Sort By:
Heart (British Cardiac Society)
|
March 11, 2021
Improving the diagnosis of heart failure in patients with atrial fibrillation
Karina V Bunting, Simrat K Gill, Alice Sitch, et al.
JAMA
|
December 22, 2020
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial
Dipak Kotecha, Karina V Bunting, Simrat K Gill, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2014
Rehabilitation aimed at improving outdoor mobility for people after stroke: a multicentre randomised controlled study (the Getting out of the House Study)
Philippa A Logan, Sarah Armstrong, Tony J Avery, et al.
JAMA
|
January 27, 2025
Negative Pressure Dressings to Prevent Surgical Site Infection After Emergency Laparotomy: The SUNRRISE Randomized Clinical Trial
, Kristy Atherton, James Brown, et al.
Critical Care Explorations
|
February 2, 2024
Providing Remote Aid During a Humanitarian Crisis
Lewis J Kaplan, Scott Levin, Jay Yelon, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial
Nicola C Edwards, Anna M Price, Samir Mehta, et al.
JAMA Pediatrics
|
December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial
Martin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)
|
January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT
Martin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pharmacoeconomics - Open
|
June 22, 2022
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
Nafsika Afentou, Emma Frew, Samir Mehta, et al.
American Heart Journal
|
September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Manvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 263) with videos related to
Sort By:
Page
of 27
Heart (British Cardiac Society)
|
March 11, 2021
Improving the diagnosis of heart failure in patients with atrial fibrillation
Karina V Bunting, Simrat K Gill, Alice Sitch, et al.
JAMA
|
December 22, 2020
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial
Dipak Kotecha, Karina V Bunting, Simrat K Gill, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2014
Rehabilitation aimed at improving outdoor mobility for people after stroke: a multicentre randomised controlled study (the Getting out of the House Study)
Philippa A Logan, Sarah Armstrong, Tony J Avery, et al.
JAMA
|
January 27, 2025
Negative Pressure Dressings to Prevent Surgical Site Infection After Emergency Laparotomy: The SUNRRISE Randomized Clinical Trial
, Kristy Atherton, James Brown, et al.
Critical Care Explorations
|
February 2, 2024
Providing Remote Aid During a Humanitarian Crisis
Lewis J Kaplan, Scott Levin, Jay Yelon, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 31, 2021
Effects of Spironolactone and Chlorthalidone on Cardiovascular Structure and Function in Chronic Kidney Disease: A Randomized, Open-Label Trial
Nicola C Edwards, Anna M Price, Samir Mehta, et al.
JAMA Pediatrics
|
December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial
Martin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)
|
January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT
Martin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pharmacoeconomics - Open
|
June 22, 2022
Economic Evaluation of Using Daily Prednisolone versus Placebo at the Time of an Upper Respiratory Tract Infection for the Management of Children with Steroid-Sensitive Nephrotic Syndrome: A Model-Based Analysis
Nafsika Afentou, Emma Frew, Samir Mehta, et al.
American Heart Journal
|
September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
Manvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Page
of 27